Lewes, DE -- (SBWIRE) -- 10/07/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Telkonet, Inc. (OTCBB:TKOI), VUZIX CORP CMN STK (OTCBB:VUZI), International Stem Cell Corp (OTCMKTS:ISCO), Transgenomic Inc (OTCMKTS:TBIO).
Telkonet, Inc. (OTCBB:TKOI) opened its last trade at the price of $0.26. Its closing price was $0.218 after losing -14.51% for the day. The company traded with the total volume of 1.59 million shares, while its average trading volume remained 74.532 shares. The beta of this stock stands at 1.20. Telkonet, Inc. provides EcoSmart energy management technology and EthoStream high-speed Internet access solutions primarily in the United States. Its EcoSmart suite of products provides savings, management, and reporting of a building's room-by-room energy consumption solutions.
Will TKOI Get Buyers Even After The Recent Rally? Find Out Here
VUZIX CORP CMN STK (OTCBB:VUZI) percentage change surged 1.83% to close at $2.23 with the total traded volume of 88.453 shares while its average volume of 65.182 shares. The 52 week range of the stock remained $1.75 - $9.75, while its day lowest price was $2.16. The share price hit the day highest price of $2.25. Vuzix Corporation engages in the design, manufacture, marketing, and sale of products for use in the consumer, and media and entertainment markets.
Will VUZI Continue To Move Higher? Find Out Here
International Stem Cell Corp (OTCMKTS:ISCO) traded on volume of 701.074 shares in the last session against average volume of 559.451 shares. The company started its trading session with the price of $0.16 and closed at $0.150 by scoring -3.23%. In the last three months the stock was down -37.24% while its 52 week ranges of the stock was $0.13 - $0.41. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally.
Will ISCO Get Buyers Even After The Recent Rally? Find Out Here
Transgenomic Inc (OTCMKTS:TBIO) started its last trading session with the price of $0.46 and closed at $0.500 by scoring 8.70%. The stock traded with total volume of 828.497 shares, while the average trading volume remained 72.732 shares. The beta value of this stock stands at 1.68. Day range for the stock was $0.42 and $0.50. Transgenomic, Inc. operates as a biotechnology company in the United States, Italy, the United Kingdom, Germany, France, and internationally.
Will TBIO Continue To Move Higher? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)